HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Fantin Selected Research

Alessandro Fantin Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 08/2010
4Pathologic Neovascularization
01/2016 - 02/2014
3Eye Diseases (Eye Disease)
01/2016 - 10/2011
2Edema (Dropsy)
01/2021 - 01/2018
2Hypoxia (Hypoxemia)
01/2016 - 10/2011
1Pathologic Processes
01/2021
1Delayed Puberty
01/2018
1Neoplasm Metastasis (Metastasis)
01/2016
1Choroidal Neovascularization
01/2016
1Kallmann Syndrome (Kallmann's Syndrome)
06/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2015
1Macular Degeneration (Age-Related Maculopathy)
01/2015
1Retinal Vein Occlusion
10/2011

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 02/2014
2Semaphorins (Semaphorin)IBA
01/2021 - 06/2015
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2018 - 06/2015
2Neuropilin-1IBA
01/2016 - 02/2014
2Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 06/2014
1ChromatinIBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1CytokinesIBA
01/2018
1Oxygen (Dioxygen)IBA
01/2016
1AcidsIBA
01/2016
1Epidermal Growth Factor (EGF)IBA
01/2016
12-O-benzylinositol 1,3,4,5,6-pentakisphosphateIBA
01/2016
1Phospholipases (Phospholipase)IBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1Semaphorin-3AIBA
01/2016
1Complement System Proteins (Complement)IBA
06/2014
1bcr-abl Fusion ProteinsIBA
06/2014
1Retinaldehyde (Retinal)IBA
10/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2010

Therapy/Procedure

4Therapeutics
01/2021 - 06/2014